{
    "clinical_study": {
        "@rank": "28307", 
        "arm_group": [
            {
                "arm_group_label": "heliox", 
                "arm_group_type": "Active Comparator", 
                "description": "Heliox is use in this group"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Oxygen is used in this group"
            }
        ], 
        "brief_summary": {
            "textblock": "Heliox can lower respiratory resistance, improve the oxygenation, reduce respiratory\n      distress and lung injury caused by mechanical ventilation."
        }, 
        "brief_title": "Heliox in Preterm Infants With Respiratory Distress Syndrome", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "condition": "Respiratory Distress Syndrome", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Newborn", 
                "Respiratory Distress Syndrome, Adult"
            ]
        }, 
        "detailed_description": {
            "textblock": "Heliox can improve the oxygenation, reduce respiratory distress and lung injury caused by\n      mechanical ventilation.\n\n      Heliox has not been widely used. More studies on the effects and safety of Heliox in\n      addition to NIPPV and mechanical ventilation should be tried."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gestational age more than 28 weeks and less than 32 weeks\n\n          -  Diagnosed as respiratory distress syndrome\n\n          -  Need to use NIPPV ventilation\n\n          -  No congenital diseases or hereditary diseases\n\n          -  With an informed consent form\n\n        Exclusion Criteria:\n\n          -  With congenital diseases or hereditary diseases\n\n          -  Intubated in the delivery room\n\n          -  Need surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "37 Weeks", 
            "minimum_age": "28 Weeks"
        }, 
        "enrollment": {
            "#text": "36", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 7, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01759316", 
            "org_study_id": "Lixue"
        }, 
        "intervention": {
            "arm_group_label": [
                "heliox", 
                "Placebo"
            ], 
            "description": "heliox or oxygen is used in the two groups respectively", 
            "intervention_name": "heliox", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 25, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "China", 
                        "country": "China", 
                        "state": "Chongqing", 
                        "zip": "400042"
                    }, 
                    "name": "Daping Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chongqing", 
                        "country": "China"
                    }, 
                    "name": "Daping Hospital and Research Institute of Surgery"
                }
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Nasal Intermittent Positive Pressure Ventilation and Mechanical Ventilation With Heliox in Preterm Infants With Respiratory Distress Syndrome", 
        "overall_official": {
            "affiliation": "Dpartment of Pediatrics, Daping Hospital, Third Military Medical University", 
            "last_name": "Yuan Shi, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome is the length of ventilation and risk of mechanical ventilation of participants.", 
            "measure": "length of ventilation and risk of mechanical ventilation", 
            "safety_issue": "Yes", 
            "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01759316"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Third Military Medical University", 
            "investigator_full_name": "Yuan Shi", 
            "investigator_title": "Director, Head of Pediatrics, Principal Investigator, Clinical Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Transcutaneous blood gas analysis\uff0cventilator parameters and lung inflammation cytokines", 
            "safety_issue": "Yes", 
            "time_frame": "participants will be followed for the duration of hospital stay, an expected average of 2 weeks"
        }, 
        "source": "Third Military Medical University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Third Military Medical University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}